Showing 4,081 - 4,100 results of 6,719 for search '"Diabetes"', query time: 0.13s Refine Results
  1. 4081
  2. 4082

    Mapping evidence on barriers to and facilitators of diagnosing noncommunicable diseases (NCDs) among people living with human immunodeficiency virus (PLWH) in low- and middle-incom... by Abebe Sorsa Badacho, Ozayr Harron Mahomed

    Published 2023-01-01
    “…<h4>Background</h4>Noncommunicable diseases (NCDs) represent a global public health challenge in all population groups, but the prevalence of major NCDs, such as depression, hypercholesterolemia, hypertension, obesity and diabetes, is increasing at a rapid rate among people living with human immunodeficiency virus (PLWH). …”
    Get full text
    Article
  3. 4083
  4. 4084
  5. 4085
  6. 4086

    Scoping review: relationship between glucose tolerance and pulmonary decline in cystic fibrosis by Raina Tomoda, Deborah Jane Holmes-Walker

    Published 2024-10-01
    “… Cystic fibrosis-related diabetes (CFRD) causes deterioration of cystic fibrosis (CF) lung disease, thereby increasing mortality. …”
    Get full text
    Article
  7. 4087

    Risk Factors and Consequent Diseases of Atherosclerosis in a Population Treated in a Medical Office by Luis Ángel Felicó Riverón, Georgia Díaz-Perera Fernández, Yomeidis Felicó Riverón

    Published 2024-11-01
    “…Overweight and obesity has the highest risk associated with altered waist circumference; arterial hypertension with type 2 diabetes mellitus; dyslipidemia with family history of dyslipidemia; and type 2 diabetes mellitus with dyslipidemia and with a family history of type 2 diabetes mellitus. …”
    Get full text
    Article
  8. 4088
  9. 4089
  10. 4090
  11. 4091
  12. 4092
  13. 4093

    In Vivo and Ex Vivo Evaluation of 1,3-Thiazolidine-2,4-Dione Derivatives as Euglycemic Agents by Diana Alemán-González-Duhart, Samuel Álvarez-Almazán, Miguel Valdes, Feliciano Tamay-Cach, Jessica Elena Mendieta-Wejebe

    Published 2021-01-01
    “…Thiazolidinediones (TZDs), used to treat type 2 diabetes mellitus, act as full agonists of the peroxisome proliferator-activated receptor gamma. …”
    Get full text
    Article
  14. 4094

    A Simple Matter of Life and Death—The Trials of Postnatal Beta-Cell Mass Regulation by Elena Tarabra, Stella Pelengaris, Michael Khan

    Published 2012-01-01
    “…Defective beta-cell numbers and/or function underlie essentially all major forms of diabetes and must be restored if diabetes is to be cured. …”
    Get full text
    Article
  15. 4095

    Homeostatic T Cell Proliferation after Islet Transplantation by Paolo Monti, Lorenzo Piemonti

    Published 2013-01-01
    “…Pancreatic islet transplantation in patients with type 1 diabetes mellitus is performed under immunosuppression to avoid alloreactive T cell responses and to control the reactivation of autoreactive memory T cells. …”
    Get full text
    Article
  16. 4096

    Creating a Perioperative Glycemic Control Program by Sara M. Alexanian, Marie E. McDonnell, Shamsuddin Akhtar

    Published 2011-01-01
    “…Here, we detail the strategies that our institutions have employed to identify and treat hyperglycemia in patients with diabetes who present for surgery. Our approach focuses on the recognition of hyperglycemia and metabolic abnormalities, control of glucose levels via insulin infusion when needed, monitoring for hypoglycemia and a comprehensive multidisciplinary approach that provides standardized recommendations for patients at all points in care as they transition from the preoperative clinic into the operating room, and then into the hospital.…”
    Get full text
    Article
  17. 4097

    Association of Differing Qatari Genotypes with Vitamin D Metabolites by Youssra Dakroury, Alexandra E. Butler, Soha R. Dargham, Aishah Latif, Amal Robay, Ronald G. Crystal, Stephen L. Atkin

    Published 2020-01-01
    “…Methods. 398 Qatari subjects (220 type 2 diabetes and 178 controls) had their genotype determined by Affymetrix 500 k SNP arrays. …”
    Get full text
    Article
  18. 4098

    Impact of a Novel Insulin Management Service on Non-insulin Pharmaceutical Expenses by John E. Schneider, Anjani Parikh, Ivana Stojanovic

    Published 2018-02-01
    “…**Background:** Studies have shown that improvements in glycemic control are associated with avoidance or delayed onset of diabetes complications, improvements in health-related quality of life, and reductions in diabetes-related health care costs. …”
    Get full text
    Article
  19. 4099
  20. 4100

    Prevalence of Lp(a) in a real-world Portuguese cohort: implications for cardiovascular risk assessment by Miguel Saraiva, Jonatas Garcez, Beatriz Tavares da Silva, Inês Poças Ferreira, José Carlos Oliveira, Isabel Palma

    Published 2025-01-01
    “…Additionally, a significant association was found between elevated Lp(a) levels and traditional CVD risk factors, including hypertension, dyslipidemia, and diabetes mellitus. Among those classified as having low-to-moderate CVD risk by (Systematic COronary Risk Evaluation 2) SCORE2, 55.7% exhibited high Lp(a) levels (> 75 nmol/L), suggesting a potential higher risk of CVD disease. …”
    Get full text
    Article